{"disease":{"id":"primary-immune-thrombocytopenia","name":"primary immune thrombocytopenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05333861","title":"An Observational, Multicenter Study to Evaluate the Safety and Effectiveness of Hetrombopag in Patients With ITP or AA","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1150,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06408324","title":"Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe","phase":"","overall_status":"COMPLETED","enrollment_count":275,"lead_sponsor_name":"European Research Consortium on ITP","has_results":false},{"nct_id":"NCT05029635","title":"Phase III Study on HMPL-523 for Treatment of ITP","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":272,"lead_sponsor_name":"Hutchison Medipharma Limited","has_results":false},{"nct_id":"NCT05653349","title":"Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":226,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04518475","title":"Eltrombopag Combining Rituximab Versus Eltrombopag in the Management of Primary Immune Thrombocytopenia (ITP) in Adults","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":224,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05621330","title":"Efficacy and Safety of QL0911 in Adult Patients With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":216,"lead_sponsor_name":"Qilu Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT04687072","title":"A Study to Evaluate the Efficacy and Safety of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"argenx","has_results":true},{"nct_id":"NCT06004856","title":"Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Chronic Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":195,"lead_sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","has_results":false},{"nct_id":"NCT04812925","title":"A Phase 3 Study to Evaluate the Safety and Efficacy of Efgartigimod PH20 Subcutaneous in Adult Patients With Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":173,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT05718856","title":"TPO-RAs Combining Anti-CD 20 Monoclonal Antibody Versus TPO-RAs in the Management of Pediatric Primary Immune Thrombocytopenia (ITP)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":166,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT07421167","title":"A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":164,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05583838","title":"A Randomized Trial Comparing Optimized rhTPO Treatment With Eltrombopag Treatment in Pre-treated ITP Pts","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":157,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05653219","title":"A Study of Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":152,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07189910","title":"Sequential rhTPO and Eltrombopag Following Glucocorticoids for Severe Adult ITP","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05338190","title":"Efficacy and Safety of Subcutaneous Belimumab or Placebo in Addition of Rituximab in Persistent or Chronic Immune Thrombocytopenia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":132,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04188379","title":"A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"argenx","has_results":true},{"nct_id":"NCT06658834","title":"A Study of Romiplostim N01 as the First-line Treatment for Newly Diagnosed Adult Patients With ITP","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":129,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT05325593","title":"Romiplostim Plus Dexamethasone vs Dexamethasone in Patients With Newly Diagnosed Primary Immune Thrombocytopenia","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":129,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT06992128","title":"Romiplostim N01 Combined With Glucocorticoids as the First-line Treatment for Newly Diagnosed Adult Primary Immune Thrombocytopenia: A Multicenter, Interventional Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":129,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04225156","title":"A Long-term Study to Assess the Safety and Efficacy of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":101,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06531018","title":"Role of Eltrombopag as First Line Therapy in Primary Immune Thrombocytopenia.","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":100,"lead_sponsor_name":"Renata PLC","has_results":false},{"nct_id":"NCT06665308","title":"Cognitive Status, Fatigue and Inflammation in Patients With Immune Thrombocytopenia (ITP)","phase":"","overall_status":"COMPLETED","enrollment_count":97,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT03771378","title":"Efficacy and Safety of rhTPO and Eltrombopag in Patients With Primary Immune Thrombocytopenia (ITP)","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT05070845","title":"Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":91,"lead_sponsor_name":"Pfizer","has_results":false},{"nct_id":"NCT04100876","title":"Effect of DNMT SNPs on DNA Methylation in Primary ITP","phase":"","overall_status":"UNKNOWN","enrollment_count":90,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT02042560","title":"Study of Immune Thrombocytopenia Pathogenesis:","phase":"","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Centre Hospitalier Universitaire Dijon","has_results":false},{"nct_id":"NCT05311930","title":"Efficacy and Safety of TPO Receptor Agonists in the Treatment of Elderly ITP Patients","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":69,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06594146","title":"Study of CM313 (SC) Injection in Subjects With Primary Immune Thrombocytopenia (ITP)","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":62,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT07039422","title":"Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT03275740","title":"A First in HumanTrial to Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-06755347","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":58,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT06071520","title":"Andalusian Experience in the Use of Fostamatinib in Patients With ITP. FOSTASUR Study","phase":"","overall_status":"COMPLETED","enrollment_count":50,"lead_sponsor_name":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","has_results":false},{"nct_id":"NCT04596995","title":"A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":43,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT05885555","title":"A Study of Ianalumab (VAY736) in Patients With Primary Immune Thrombocytopenia (ITP) Previously Treated With at Least Two Lines of Therapies","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":41,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04278924","title":"A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT03102593","title":"A Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of ARGX-113 in Patients With ITP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT06686927","title":"Study on Glucocorticoid Combined With Gamma Globulin and Ropristine N01 in Treatment of Initial Severe ITP","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":36,"lead_sponsor_name":"Union Hospital, Tongji Medical College, Huazhong University of Science and Technology","has_results":false},{"nct_id":"NCT06148389","title":"The Safety and Tolerability of STSA-1301 Subcutaneous Injection in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Staidson (Beijing) Biopharmaceuticals Co., Ltd","has_results":false},{"nct_id":"NCT04200456","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":33,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT05422365","title":"Intravenous Immunoglobulin (IVIG, Bioven) Efficacy and Safety in Chronic Primary Immune Thrombocytopenia (ITP) in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Biopharma Plasma LLC","has_results":true},{"nct_id":"NCT05232149","title":"A Study to Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Immune Thrombocytopenia","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Beijing InnoCare Pharma Tech Co., Ltd.","has_results":false},{"nct_id":"NCT04224688","title":"A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"UCB Biopharma SRL","has_results":true},{"nct_id":"NCT07400250","title":"Phase II Study of Orelabrutinib in Combination With Romiplostim N01 in Patients With Primary Immune Thrombocytopenia (ITP) Who Have Received At Least One Prior Line of Therapy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06888960","title":"Safety Study of CC312 in Autoimmune Disease Patients","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":18,"lead_sponsor_name":"CytoCares Inc","has_results":false},{"nct_id":"NCT05551624","title":"Evaluation of the Effect in Platelet Count of Atorvastatin and N-acetyl Cysteine","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Hospital Civil de Guadalajara","has_results":false},{"nct_id":"NCT07019545","title":"A PHASE II TRIAL AIMING TO INVESTIGATE THE SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN IN ADULT PATIENTS WITH PRIMARY IMMUNE THROMBOCYTOPENIA PREVIOUSLY TREATED WITH A THROMBOPOIETIN RECEPTOR AGONIST AND/OR RITUXIMAB AFTER CORTICOSTEROID FIRST-LINE THERAPY","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":14,"lead_sponsor_name":"Hellenic Society of Hematology","has_results":false},{"nct_id":"NCT06880081","title":"Study of PN20 in Adult Patients With Primary Immune Thrombocytopenia (ITP)","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Chongqing Peg-Bio Biopharm Co., Ltd.","has_results":false},{"nct_id":"NCT05371743","title":"Plasma microRNA Levels and Some Cytokines Expression in Patients With ITP Primary Immune Thrombocytopenic Purpura (ITP)","phase":"","overall_status":"UNKNOWN","enrollment_count":2,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04812483","title":"Immunomodulation With Eltrombopag in ITP","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University Children's Hospital Basel","has_results":false},{"nct_id":"NCT04274452","title":"A Study to Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"argenx","has_results":false},{"nct_id":"NCT07244289","title":"Managed Access Programs for VAY736, Ianalumab","phase":"","overall_status":"AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}